254 related articles for article (PubMed ID: 27108698)
1. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
[TBL] [Abstract][Full Text] [Related]
2. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
[TBL] [Abstract][Full Text] [Related]
3. C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages.
Li XX; Clark RJ; Woodruff TM
J Immunol; 2020 Aug; 205(4):1102-1112. PubMed ID: 32611725
[TBL] [Abstract][Full Text] [Related]
4. The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production.
Pundir P; MacDonald CA; Kulka M
J Immunol; 2015 Sep; 195(6):2774-87. PubMed ID: 26283482
[TBL] [Abstract][Full Text] [Related]
5. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
[TBL] [Abstract][Full Text] [Related]
6. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
[TBL] [Abstract][Full Text] [Related]
8. The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.
Seiler DL; Kähler KH; Kleingarn M; Sadik CD; Bieber K; Köhl J; Ludwig RJ; Karsten CM
Front Immunol; 2023; 14():1197709. PubMed ID: 37275893
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
10. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
[TBL] [Abstract][Full Text] [Related]
11. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
12. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
Das A; Gupta PK; Rana S
J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
[TBL] [Abstract][Full Text] [Related]
13. The C5a/C5aR2 axis promotes renal inflammation and tissue damage.
Zhang T; Wu KY; Ma N; Wei LL; Garstka M; Zhou W; Li K
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32191644
[TBL] [Abstract][Full Text] [Related]
14. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
Yu S; Wang D; Huang L; Zhang Y; Luo R; Adah D; Tang Y; Zhao K; Lu B
J Biol Chem; 2019 May; 294(21):8384-8394. PubMed ID: 30971430
[TBL] [Abstract][Full Text] [Related]
15. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
16. C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2.
Van Lith LH; Oosterom J; Van Elsas A; Zaman GJ
J Biomol Screen; 2009 Oct; 14(9):1067-75. PubMed ID: 19641221
[TBL] [Abstract][Full Text] [Related]
17. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.
Zhang T; Garstka MA; Li K
J Immunol Res; 2017; 2017():8193932. PubMed ID: 28706957
[TBL] [Abstract][Full Text] [Related]
18. C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment.
Croker DE; Halai R; Kaeslin G; Wende E; Fehlhaber B; Klos A; Monk PN; Cooper MA
Immunol Cell Biol; 2014 Aug; 92(7):631-9. PubMed ID: 24777312
[TBL] [Abstract][Full Text] [Related]
19. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
Sadik CD; Miyabe Y; Sezin T; Luster AD
Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
[TBL] [Abstract][Full Text] [Related]
20. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2.
Croker DE; Halai R; Fairlie DP; Cooper MA
Immunol Cell Biol; 2013; 91(10):625-33. PubMed ID: 24060963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
